Merck Kgaa (MKGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MKGAF | UTHR | NBIX | ||
| Company | Merck Kgaa | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 165.8100 | 550.59 | 181.00 | ||
| High | 166.2290 | 553.47 | 181.18 | ||
| Low | 157.5810 | 539.33 | 174.21 | ||
| Latest | 164.1500 | 547.06 | 177.11 | ||
| Change | +2.9400 | -5.42 | -3.44 | ||
| % Change | +1.82% | -0.98% | -1.91% | ||
| Volume | 100 | 307,700 | 1,047,400 | ||
| 20-Day Average Volume | 475 | 563,575 | 1,194,065 | ||
| Previous Close | 161.2100 | 552.48 | 180.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 161.4849 | 547.52 | 167.28 | ||
| 20-Day Raw Stochastic | 58.96% | 46.51% | 84.27% | ||
| 20-Day Relative Strength | 55.05 | 47.88 | 65.45 | ||
| Weighted Alpha | +28.53 | +56.98 | +41.31 | ||
| Today's Opinion | 100% Buy | 16% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 48% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.44% since 07/02/26 | -1.59% since 07/02/26 | +1.64% since 07/02/26 | ||
| Low | 157.5810 on 07/10/26 | 539.33 on 07/10/26 | 171.14 on 07/06/26 | ||
| High | 170.1500 on 07/06/26 | 563.70 on 07/07/26 | 181.18 on 07/10/26 | ||
| 1-Month | |||||
| %Chg | +3.76% since 06/10/26 | +0.54% since 06/10/26 | +10.10% since 06/10/26 | ||
| Low | 147.7620 on 06/18/26 | 532.59 on 06/18/26 | 155.30 on 06/16/26 | ||
| High | 175.5590 on 07/02/26 | 563.70 on 07/07/26 | 181.18 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | +20.51% since 04/10/26 | -4.31% since 04/10/26 | +37.41% since 04/10/26 | ||
| Low | 122.4500 on 04/29/26 | 532.59 on 06/18/26 | 125.64 on 04/13/26 | ||
| High | 175.5590 on 07/02/26 | 609.35 on 05/06/26 | 181.18 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | +11.67% since 01/09/26 | +13.21% since 01/09/26 | +30.43% since 01/09/26 | ||
| Low | 116.6800 on 03/23/26 | 455.63 on 01/20/26 | 122.14 on 02/12/26 | ||
| High | 175.5590 on 07/02/26 | 609.35 on 05/06/26 | 181.18 on 07/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 21,873,870 | 23,221,050 | 17,808,412 | ||
| Shares Outstanding, K | 129,240 | 42,447 | 100,550 | ||
| Annual Sales | 22,720,720,000 | 3,182,700,000 | 2,860,500,000 | ||
| Annual Net Income | 3,056,420,000 | 1,334,700,000 | 478,600,000 | ||
| Last Quarter Sales | 5,763,570,000 | 781,500,000 | 814,500,000 | ||
| Last Quarter Net Income | 653,680,000 | 274,900,000 | 197,900,000 | ||
| 60-Month Beta | 0.96 | 0.58 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.51 on 08/01/24 | 5.82 on 05/06/26 | 1.94 on 05/05/26 | ||
| Earnings Date | 11/14/24 | 07/29/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.55 | 20.39 | 30.40 | ||